A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension-Reference-Cited by-同舟云学术

A New NO-Releasing Nanoformulation for the Treatment of Pulmonary Arterial Hypertension

Published:2016-03-09 Issue:2 Volume:9 Page:162-164
ISSN:1937-5387
Container-title:Journal of Cardiovascular Translational Research
language:en
Short-container-title:J. of Cardiovasc. Trans. Res.

Author:

Mohamed Nura A.,Ahmetaj-Shala Blerina,Duluc Lucie,Mackenzie Louise S.,Kirkby Nicholas S.,Reed Daniel M.,Lickiss Paul D.,Davies Robert P.,Freeman Gemma R.,Wojciak-Stothard Beata,Chester Adrian H.,El-Sherbiny Ibrahim M.,Mitchell Jane A.,Yacoub Magdi H.

Funder

Qatar Foundation for research and human development (QF)

Magdi Yacoub Institute (MYI)

Publisher

Springer Science and Business Media LLC

Subject

Genetics(clinical),Cardiology and Cardiovascular Medicine,Pharmaceutical Science,Genetics,Molecular Medicine

Link

http://link.springer.com/content/pdf/10.1007/s12265-016-9684-2.pdf

Reference5 articles.

1. Ghofrani, H. A., & Humbert, M. (2014). The role of combination therapy in managing pulmonary arterial hypertension. European Respiratory Review, 23(134), 469–475.

2. Archer, S. L., Weir, E. K., & Wilkins, M. R. (2010). Basic science of pulmonary arterial hypertension for clinicians: new concepts and experimental therapies. Circulation, 121(18), 2045–2066.